resveratrol has been researched along with Endometrial Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, X; Zheng, Y; Zhong, Z | 1 |
| Dann, JM; Evans, JJ; Mason, DR; Sykes, PH | 1 |
| Boehme, K; Mueller, SO; Simon, S | 1 |
| Hanley, G; Li, H; Li, Y; Sun, X; Wang, J; Wei, L; Yin, D; Zhang, Y; Zhao, M | 1 |
| Chitcholtan, K; Dann, JM; Evans, JJ; Guilford, P; Harris, G; Lewis, LK; Nagase, J; Sykes, PH; Welkamp, AA; Zwerus, R | 1 |
| Dahiya, R; Kaneuchi, M; Sakuragi, N; Sasaki, M; Tanaka, Y; Yamamoto, R | 1 |
| Asselin, E; LeBlanc, K; Lemoine, P; Parent, S; Sexton, E; Van Themsche, C | 1 |
| Bhat, KP; Pezzuto, JM | 1 |
8 other study(ies) available for resveratrol and Endometrial Neoplasms
| Article | Year |
|---|---|
Network Pharmacology-Based and Molecular Docking Analysis of Resveratrol's Pharmacological Effects on Type I Endometrial Cancer.
Topics: Drugs, Chinese Herbal; Endometrial Neoplasms; Female; Humans; Medicine, Chinese Traditional; Molecular Docking Simulation; Network Pharmacology; Resveratrol | 2022 |
Regulation of Vascular Endothelial Growth Factor in endometrial tumour cells by resveratrol and EGCG.
Topics: Anticarcinogenic Agents; Catechin; Endometrial Neoplasms; Enzyme-Linked Immunosorbent Assay; Female; Humans; Resveratrol; Stilbenes; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2009 |
Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds.
Topics: Benzhydryl Compounds; Cell Line, Tumor; Cluster Analysis; DDT; Diethylstilbestrol; Endocrine Disruptors; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genistein; Humans; Oligonucleotide Array Sequence Analysis; Phenols; Phytoestrogens; Polymerase Chain Reaction; Receptors, Estrogen; Reproducibility of Results; Resveratrol; Risk Assessment; RNA, Messenger; Stilbenes; Time Factors; Zearalenone | 2009 |
Beta-arrestin 2 modulates resveratrol-induced apoptosis and regulation of Akt/GSK3ß pathways.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Arrestins; beta-Arrestin 2; beta-Arrestins; Caspase 3; Cell Line, Tumor; Endometrial Neoplasms; Enzyme Activation; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Phosphorylation; Proto-Oncogene Proteins c-akt; Resveratrol; RNA Interference; Signal Transduction; Stilbenes | 2010 |
Adrenomedullin interacts with VEGF in endometrial cancer and has varied modulation in tumours of different grades.
Topics: Adenocarcinoma; Adrenomedullin; Biomarkers, Tumor; Case-Control Studies; Catechin; Cell Line, Tumor; Cobalt; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Grading; Resveratrol; RNA, Messenger; Stilbenes; Up-Regulation; Vascular Endothelial Growth Factor A | 2012 |
Resveratrol suppresses growth of Ishikawa cells through down-regulation of EGF.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Cycle; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Endometrial Neoplasms; Epidermal Growth Factor; Female; Humans; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Time Factors | 2003 |
Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells.
Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Endometrial Neoplasms; Female; HeLa Cells; Humans; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; Uterine Neoplasms | 2006 |
Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Topics: Adenocarcinoma; Alkaline Phosphatase; Antigens, CD; Antineoplastic Agents, Phytogenic; CDC2-CDC28 Kinases; Cell Survival; Cyclin A; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Down-Regulation; Drug Interactions; Endometrial Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; Gene Expression Regulation, Neoplastic; Humans; Integrin alpha1; Protein Serine-Threonine Kinases; Receptors, Estrogen; Receptors, Progesterone; Resveratrol; RNA, Messenger; S Phase; Stilbenes; Transcriptional Activation; Tumor Cells, Cultured | 2001 |